Vijay Kumar Jain, Karthikeyan P Iyengar, David Ananth Samy, Raju Vaishya
{"title":"Tuberculosis in the era of COVID-19 in India.","authors":"Vijay Kumar Jain, Karthikeyan P Iyengar, David Ananth Samy, Raju Vaishya","doi":"10.1016/j.dsx.2020.07.034","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.07.034","url":null,"abstract":"<p><strong>Background and aims: </strong>Tuberculosis (TB) still continues to be endemic in various regions of the world, including in India and needs surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens for an effective eradication. We assess the challenges due to COVID- 19 pandemic on management of Tuberculosis and current strategies adopted to mitigate them.</p><p><strong>Methods: </strong>We carried out a comprehensive review of the literature using suitable keywords such as 'COVID-19', 'Pandemics', 'Tuberculosis' and 'India' on the search engines of PubMed, Scopus, Google Scholar and Research Gate in the month of May 2020 during the current COVID-19 pandemic to assess the impact of COVID-19 on management of Tuberculosis.</p><p><strong>Results: </strong>We found considerable disruption in Tuberculosis service provisions both in the primary care and hospital settings. Lockdown, social distancing, isolation strategies and public health guidelines to prevent viral transmission impacted the delivery of all aspects of Tuberculosis care.</p><p><strong>Conclusions: </strong>COVID-19 pandemic has had a significant impact in the delivery of various tuberculosis prevention, surveillance, and treatment programmes. Lockdown and public health guidelines have resulted in tough challenges in traditional management of tuberculosis and has required reconfiguration of methods to support patients including wider use of remote consultations.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1439-1443"},"PeriodicalIF":10.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.07.034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38240180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ARIMA modelling & forecasting of COVID-19 in top five affected countries.","authors":"Alok Kumar Sahai, Namita Rath, Vishal Sood, Manvendra Pratap Singh","doi":"10.1016/j.dsx.2020.07.042","DOIUrl":"10.1016/j.dsx.2020.07.042","url":null,"abstract":"<p><strong>Background and aims: </strong>In a little over six months, the Corona virus epidemic has affected over ten million and killed over half a million people worldwide as on June 30, 2020. With no vaccine in sight, the spread of the virus is likely to continue unabated. This article aims to analyze the time series data for top five countries affected by the COVID-19 for forecasting the spread of the epidemic.</p><p><strong>Material and methods: </strong>Daily time series data from 15th February to June 30, 2020 of total infected cases from the top five countries namely US, Brazil, India, Russia and Spain were collected from the online database. ARIMA model specifications were estimated using Hannan and Rissanen algorithm. Out of sample forecast for the next 77 days was computed using the ARIMA models.</p><p><strong>Results: </strong>Forecast for the first 18 days of July was compared with the actual data and the forecast accuracy was using MAD and MAPE were found within acceptable agreement. The graphic plots of forecast data suggest that While Russia and Spain have reached the inflexion point in the spread of epidemic, the US, Brazil and India are still experiencing an exponential curve.</p><p><strong>Conclusion: </strong>Our analysis shows that India and Brazil will hit 1.38 million and 2.47 million mark while the US will reach the 4.29 million mark by 31st July. With no effective cure available at the moment, this forecast will help the governments to be better prepared to combat the epidemic by ramping up their healthcare facilities.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1419-1427"},"PeriodicalIF":3.4,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38231974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Letter in response to letter to the editor by Singh and Dhibar regarding the article \"COVID-19: From bench to bedside\" (Singh et al.).","authors":"Akriti Singh, Altamash Shaikh, Ritu Singh, Awadhesh Kumar Singh","doi":"10.1016/j.dsx.2020.06.012","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.06.012","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"865"},"PeriodicalIF":10.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.06.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38070496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yogini V Chudasama, Francesco Zaccardi, Kamlesh Khunti
{"title":"Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.).","authors":"Yogini V Chudasama, Francesco Zaccardi, Kamlesh Khunti","doi":"10.1016/j.dsx.2020.06.034","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.06.034","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1281"},"PeriodicalIF":10.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.06.034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38231121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stergios A Polyzos, Athanasios Mousiolis, Gesthimani Mintziori, Dimitrios G Goulis
{"title":"Nonalcoholic fatty liver disease in males with low testosterone concentrations.","authors":"Stergios A Polyzos, Athanasios Mousiolis, Gesthimani Mintziori, Dimitrios G Goulis","doi":"10.1016/j.dsx.2020.07.049","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.07.049","url":null,"abstract":"<p><strong>Aims: </strong>There are limited clinical data on the association between serum testosterone concentrations and nonalcoholic fatty liver disease (NAFLD) in men. The main aim of this study was to evaluate the association between testosterone concentrations and NAFLD in adult men, in terms of noninvasive indices of NAFLD and hepatic fibrosis.</p><p><strong>Methods: </strong>In this cross-sectional study, 98 men were recruited on an outpatient basis and were divided into low-testosterone (<12 nmol/l or <346 ng/dl, n = 37) or high-testosterone groups (≥12 nmol/l or ≥346 ng/dl, n = 61). Serum testosterone concentrations were measured by immuno-chemiluminescence. Hepatic steatosis index (HSI) and Triglyceride-to-HDL-C ratio (THR), as non-invasive indices of NAFLD, as well as AST-to-Platelet Ratio Index (APRI), fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS), as non-invasive indices of hepatic fibrosis, were calculated based on standard formulas.</p><p><strong>Results: </strong>Both the non-invasive indices of NAFLD (HSI and THR) were higher in low-testosterone compared with high-testosterone group (HSI: 47.5 ± 2.9 vs. 38.4 ± 1.0, p = 0.005; THR: 1.70 ± 0.16 vs. 0.98 ± 0.07, p < 0.001). On the contrary, none of the non-invasive indices of hepatic fibrosis was different between groups. HSI (p = 0.038), but not THR, remained inversely independently associated with serum testosterone, after adjustment for potential confounders, including sex hormone-binding globulin.</p><p><strong>Conclusions: </strong>Men with low testosterone concentrations have higher non-invasive indices of NAFLD (HSI and THR), but not of hepatic fibrosis (APRI, FIB-4, NFS), compared with counterparts of high testosterone concentrations. HSI was inversely and independently associated with testosterone concentrations.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1571-1577"},"PeriodicalIF":10.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.07.049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38395198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Response to 'Multimorbidity and SARS-CoV-2 infection in UK biobank'.","authors":"Abhipsha Sur Roy, Amol Joshi","doi":"10.1016/j.dsx.2020.06.033","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.06.033","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"969"},"PeriodicalIF":10.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.06.033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38100358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"COVID-19 and self-care strategies for women with gestational diabetes mellitus.","authors":"Fatemeh Moradi, Akram Ghadiri-Anari, Behnaz Enjezab","doi":"10.1016/j.dsx.2020.08.004","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.08.004","url":null,"abstract":"<p><strong>Background and aim: </strong>The outbreak of the emerging coronavirus disease 2019 (COVID-19) is a global public health emergency. According to the findings, women with gestational diabetes mellitus (GDM) are at increased risk of this virus. Due to the need for quarantine and social distancing in the current disease situation and need to receive repeated medical care in GDM patients, this review study aimed to evaluate the self-care strategies for women with GDM during COVID-19 pandemic.</p><p><strong>Methods: </strong>25 related articles from 2011 to 2020 and 3 guidelines were reviewed with the keywords of gestational diabetes mellitus, diabetes, pregnancy and COVID-19 in combination with self-care and self-management in PubMed, Google Scholar, Scopus, Science Direct, Elsevier, Springer, Wiley Online Library and SID.</p><p><strong>Results: </strong>According to the results of the studies, face-to-face visits should be limited and instead, telemedicine services recommended. Self-care throughout telemedicine services were improved maternal and neonatal outcomes in women with GDM.</p><p><strong>Conclusion: </strong>Although self-care program through telemedicine services is beneficial for women with GDM, performing clinical trials are recommended to assess maternal and neonatal outcomes in this condition.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1535-1539"},"PeriodicalIF":10.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38395784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diabetes care during COVID 19: Experience in telemedicine from a developing country.","authors":"Eilhart García-Villasante, Víctor Baca-Carrasco, Claudia Gutierrez-Ortiz, Isabel Pinedo-Torres","doi":"10.1016/j.dsx.2020.07.046","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.07.046","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1519"},"PeriodicalIF":10.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.07.046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38273041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}